scholarly article | Q13442814 |
P50 | author | Walter C. Willett | Q1133904 |
David J. Hunter | Q21066148 | ||
Nilanjan Chatterjee | Q21526241 | ||
Stephen Chanock | Q27662321 | ||
Kim Overvad | Q28356149 | ||
Rosario Tumino | Q28356361 | ||
Federico Canzian | Q28360459 | ||
Graham Giles | Q30524411 | ||
Melissa C. Southey | Q55446228 | ||
Tyler VanderWeele | Q56363392 | ||
Roger L. Milne | Q56855807 | ||
María José Sánchez Pérez | Q57549270 | ||
Fredrick Schumacher | Q64183024 | ||
Myrto Barrdahl | Q67212440 | ||
Julie E. Buring | Q67224421 | ||
Jonine Figueroa | Q71778357 | ||
David G. Cox | Q73023435 | ||
Christopher A. Haiman | Q73606228 | ||
Brian E. Henderson | Q73660621 | ||
Laura Baglietto | Q74010954 | ||
Susan E. Hankinson | Q76570836 | ||
Sara Lindstroem | Q77022171 | ||
Peter Kraft | Q77526208 | ||
Daniel Stram | Q85936408 | ||
Claudine Isaacs | Q90579511 | ||
Mia M. Gaudet | Q90611381 | ||
Susan M Gapstur | Q90864325 | ||
Regina G. Ziegler | Q90946208 | ||
Paul L Auer | Q99370519 | ||
Barry I. Graubard | Q100467671 | ||
Isabelle Romieu | Q107417173 | ||
Christine Berg | Q109563446 | ||
Laurence N Kolonel | Q114130594 | ||
Robert N. Hoover | Q118558329 | ||
P2093 | author name string | Amit D Joshi | |
Mitchell H Gail | |||
Ross L Prentice | |||
Paige Maas | |||
I-Min Lee | |||
William F Anderson | |||
Shumin Zhang | |||
David Check | |||
Montse Garcia-Closas | |||
Subham Chattopadhyay | |||
P2860 | cites work | 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 | Q22251112 |
Genome-wide association studies identify four ER negative-specific breast cancer risk loci | Q24622610 | ||
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
Proportion of breast cancer cases in the United States explained by well-established risk factors | Q28283778 | ||
Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions | Q34038964 | ||
Performance of common genetic variants in breast-cancer risk models | Q34064069 | ||
Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women | Q34155371 | ||
Effect of direct-to-consumer genomewide profiling to assess disease risk | Q34158574 | ||
Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer | Q34225990 | ||
Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium | Q34472668 | ||
Testing calibration of risk models at extremes of disease risk | Q34678258 | ||
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer | Q34736112 | ||
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors | Q34898735 | ||
Associations between self-referral and health behavior responses to genetic risk information | Q35030090 | ||
Risk factor modification and projections of absolute breast cancer risk | Q35090578 | ||
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium | Q35166701 | ||
Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century | Q35291344 | ||
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer | Q35996692 | ||
Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans | Q36199476 | ||
Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement | Q36393193 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors | Q36720821 | ||
Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk | Q36858843 | ||
Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status | Q37223335 | ||
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium | Q37619303 | ||
The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? | Q37673185 | ||
Global estimates of cancer prevalence for 27 sites in the adult population in 2008. | Q38920305 | ||
Design and estimation for the national health interview survey, 2006-2015. | Q51091404 | ||
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes | Q57306192 | ||
Questionnaires from the National Health Interview Survey, 1985-89 | Q72597326 | ||
Polygenes, risk prediction, and targeted prevention of breast cancer | Q81523323 | ||
Public health implications from COGS and potential for risk stratification and screening | Q86499074 | ||
P433 | issue | 10 | |
P304 | page(s) | 1295-1302 | |
P577 | publication date | 2016-05-26 | |
P1433 | published in | JAMA Oncology | Q22079683 |
P1476 | title | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States | |
P478 | volume | 2 |
Q37697979 | A clinical model for identifying the short-term risk of breast cancer |
Q92199197 | A systematic review and quality assessment of individualised breast cancer risk prediction models |
Q57748350 | Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study |
Q90051408 | Assessing thyroid cancer risk using polygenic risk scores |
Q91866775 | Assessment of breast cancer risk: which tools to use? |
Q97070156 | Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers |
Q90598883 | Association and implications in triple negative and triple positive breast cancer: Relationship with sociodemographic and reproductive factors in Pakistan |
Q57612089 | Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative |
Q38765326 | Association of alcohol intake with risk of diabetic retinopathy: a meta-analysis of observational studies |
Q57114175 | Awareness and Misconceptions of Breast Cancer Risk Factors Among Laypersons and Physicians |
Q91045517 | BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors |
Q91865303 | Benefits and limitations of genome-wide association studies |
Q87909686 | Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening |
Q91650503 | Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials |
Q101237548 | Cancer therapy shapes the fitness landscape of clonal hematopoiesis |
Q90300115 | Choosing Breast Cancer Risk Models: Importance of Independent Validation |
Q92709250 | Clinical use of current polygenic risk scores may exacerbate health disparities |
Q92240128 | Combined effect of modifiable and non-modifiable risk factors for colorectal cancer risk in a pooled analysis of 11 population-based studies |
Q92528444 | Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification |
Q57177092 | Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model |
Q47251942 | Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases |
Q45072344 | Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research. |
Q47724615 | Development of a predictive miRNA signature for breast cancer risk among high-risk women |
Q91831253 | Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders |
Q89798942 | Efficient Estimation and Applications of Cross-Validated Genetic Predictions to Polygenic Risk Scores and Linear Mixed Models |
Q88994510 | Emerging Trends in Clinical Research: With Implications for Population Health and Health Policy |
Q90367200 | Estimation of Absolute Risk of Colorectal Cancer Based on Healthy Lifestyle, Genetic Risk, and Colonoscopy Status in a Population-based Study |
Q90929499 | Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits |
Q54911668 | Evaluating Public Health Interventions: 6. Modeling Ratios or Differences? Let the Data Tell Us. |
Q37609227 | FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer |
Q48212258 | Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy |
Q64080586 | Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer |
Q96821073 | Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a randomized placebo-controlled trial |
Q100407592 | Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study |
Q64236058 | Genomic Predictors of Asthma Phenotypes and Treatment Response |
Q92046438 | Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations |
Q92711915 | Incidence of breast cancer attributable to breast density, modifiable and non-modifiable breast cancer risk factors in Singapore |
Q37360550 | Integrating precision cancer medicine into healthcare-policy, practice, and research challenges |
Q104073603 | Integrative genomic analysis implicates ERCC6 and its interaction with ERCC8 in susceptibility to breast cancer |
Q64279327 | Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk |
Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
Q33829049 | Joint modeling of genetically correlated diseases and functional annotations increases accuracy of polygenic risk prediction |
Q96230819 | Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases |
Q43843244 | Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction |
Q64945839 | Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models. |
Q96604435 | Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations |
Q64986687 | Nutrient intake patterns and breast cancer risk among Jordanian women: a case-control study. |
Q96577047 | Personalized early detection and prevention of breast cancer: ENVISION consensus statement |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q92287495 | Polygenic Susceptibility of Aortic Aneurysms Associates to the Diameter of the Aneurysm Sac: the Aneurysm-Express Biobank Cohort |
Q91788154 | Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers |
Q92638472 | Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification |
Q91791147 | Precision neuroradiology: mapping the nodes and networks that link genes to behaviour |
Q47409320 | Predictive accuracy of combined genetic and environmental risk scores |
Q57296967 | Preventative Health and Risk Behaviors Among Adolescent Girls With and Without Family Histories of Breast Cancer |
Q49923389 | Quantifying the polygenic contribution to cutaneous squamous cell carcinoma risk. |
Q53826302 | Reproductive risk factors in breast cancer and genetic hormonal pathways: a gene-environment interaction in the MCC-Spain project. |
Q61118451 | Shared heritability and functional enrichment across six solid cancers |
Q47161591 | The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol. |
Q61755960 | The Genetic Sphygmomanometer: an argument for routine genome-wide genotyping in the population and a new view on its use to inform clinical practice |
Q57299380 | The approach to predictive medicine that is taking genomics research by storm |
Q64117891 | The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease |
Q88778863 | The personal and clinical utility of polygenic risk scores |
Q47661659 | Update on the State of the Science for Analytical Methods for Gene-Environment Interactions |
Q92043569 | Use of detailed family history data to improve risk prediction,with application to breast cancer screening |
Q50281308 | Validating a breast cancer score in Spanish women. The MCC-Spain study. |
Q57040851 | Validation of a genetic risk score for Arkansas women of color |
Q97093695 | Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort |
Q58400951 | Will Precision Medicine Improve Population Health? |
Q89547730 | iCARE: An R package to build, validate and apply absolute risk models |
Search more.